Where is Citius Pharma (CTXR) in the FDA Approval Process?

We have a number of subscribers asking for an update on the FDA approval process for Mino-Lok. In layman's term (assuming approval)...
Checkpoint Theraputics

11:00 AM Webinar Today, Checkpoint Therapeutics (CKPT) CEO James Olivero.

Virtually meet the CEO of Checkpoint, James Oliviero, on May 28th at 11 am for an update on their two most advanced programs.

Update: Biotech 5 Pack. 5 Biotech Stocks, we Expected to Double in 2020.

No Doubles Yet, But They're Doing Rather Well, Considering Everything. Our Confidence Remains Unwavered. Best Performer up 63%.

True Nature | Mitesco (MITI) Raising $15 Million.

LIVE CHART Mitesco, Inc. Announces up to $15 Million Unit Preferred Capital...

Adding Organicell (BPSR) $0.02 to the Watch List.

Organicell (BBSR). New client, studying now. Thinly, thinly traded and expectedly volatile on an intra-day basis. Like what we’ve read so far...
America BriVision, Biotech Stock Review

Adding American BriVision (ABVC) $2.00 to Watch List.

New client and an incubator, studying now. Thinly, thinly traded. We like what we've read so far about their vitreous substitute (eyeball...

Our Favorite Incubator, Incubates! Telehealth in its Future?

True Nature|Mitesco has found an excellent first Company to incubate and help grow, called MyCare.The founders of the Minute Clinic are teaming...
biotech stock review ATXI

Avenue Therapeutics (ATXI) Announces New Drug Application for IV Tramadol Accepted for Review by...

IV tramadol for the management of moderate to moderately severe pain in adults in a medically supervised health care setting.

Fortress Bio (FBIO) Inches Closer to $3.00 on Major News.

Fortress Bio (FBIO) Inches Closer to $3.00 on Major News. Citius Pharma (CTXR) Inches Closer to the Next Phase...
Mitesco, Biotech Stock Review

Medtech Incubator True Nature | Mitesco (TNTY) Adds Another Heavy Hitter to Board.

True Nature Holding, Inc. DBA Mitesco, Inc. Adds Distinguished Healthcare Executive to Board of Directors.

Latest article

Clorox and P&G Struggle to Meet COVID-19-Related Spike in Demand (MarketWatch).

Clorox shares have soared more than 54% for the year to date, an increase of $11.5 billion to $29.5 billion.

Video: 2020 Year of Crisis: Markets Melt Up (Bloomberg).

https://youtu.be/eL0YyWK_pcg Ask Yourself a Question, Do I Feel...
Biotech Stock Review, Aphex BioCLeanse

Adding Aphex BioCleanse Systems (SNST) to CoronaVirus Watch List.

Former Eastman Kodak Scientist Engineers Develop Liquid Germ Killer Hy-IQ™ Water to Revolutionize how Deadly Bacteria and Virus are Eradicated